BECTON, DICKINSON AND COMPANY for BECTON DICKINSON AND COMPANY
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 20, 2017 | $370,000 | Replaced |
| 1st Quarter - Amendment | Aug 3, 2017 | $260,000 | Yes |
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to UDI on Medicare claim forms
| Lobbyist | Covered position, as disclosed |
|---|---|
| TODD SPANGLER | — |
Taxation/Internal Revenue Code TAX
H.R.184, Protect Medical Innovation Act of 2017 Issues related to corporate tax
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSICA JOHNSTON | — |
| JENNIFER M LURAY | — |
| TODD SPANGLER | — |
Health Issues HCR
Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to hazardous drug safety Issues related to opioid safety H.R.1628, American Health Care Act of 2017
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSICA JOHNSTON | — |
| JENNIFER M LURAY | — |
| DANNY LY | — |
| TODD SPANGLER | — |
Medical/Disease Research/Clinical Labs MED
Issues related to device cybersecurity
| Lobbyist | Covered position, as disclosed |
|---|---|
| TODD SPANGLER | — |
Budget/Appropriations BUD
H.R.2028, Continuing Resolution NIH Funding Global Health Funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANNY LY | — |
| TODD SPANGLER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.